ExodusPoint Capital Management, LP
Position in CATX — Perspective Therapeutics, Inc.
CIK 1736225
NEW YORK, NY
Position in CATX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$488,102
-$7,276,444 QoQ
Shares Held
117,051
-79.9% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026ExodusPoint Capital Management, LP holds $345,630,527 across 29 Medical Devices names. CATX ranks #26 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
465,215 | $152,762,649 | |
| 2 | LIVN |
LivaNova PLC
|
495,618 | $31,501,480 | |
| 3 | DXCM |
Dexcom Inc
|
317,067 | $19,911,807 | |
| 4 | BSX |
Boston Scientific Corp
|
311,363 | $19,538,028 | |
| 5 | GKOS |
GLAUKOS Corp
|
179,728 | $19,349,516 | |
| 6 | GMED |
Globus Medical Inc
|
208,902 | $17,998,996 | |
| 7 | EW |
Edwards Lifesciences Corp
|
215,124 | $17,227,129 | |
| 8 | TNDM |
Tandem Diabetes Care Inc
|
632,899 | $12,132,673 |
All Filings in CATX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $488,102 | 117,051 | Shares | Sole | 2026-05-14 | |
| 2024-09-30 | $7,764,546 | 581,614 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,942,658 | 596,054 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||